(Q44400149)

2 December 2017

title

Phase I trial of high dose paracetamol and carmustine in patients with metastatic melanoma (English)

1 reference

2 December 2017

main subject

phase I clinical trial

0 references

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1097/00008390-200304000-00013

23 December 2023

1 reference

https://api.crossref.org/works/10.1097/00008390-200304000-00013

23 December 2023

1

Jedd D Wolchok

1 reference

2 December 2017

Linda Williams

2

1 reference

2 December 2017

Martin Fleisher

4

1 reference

2 December 2017

Wen-Jen Hwu

6

1 reference

2 December 2017

Christine Chang

8

1 reference

2 December 2017

John T. Pinto

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12690304

23 December 2023

Susan E. Krown

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12690304

23 December 2023

Philip O. Livingston

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12690304

23 December 2023

Paul B. Chapman

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12690304

23 December 2023

language of work or name

English

0 references

publication date

1 April 2003

1 reference

full work available at URL

2 December 2017

http://journals.lww.com/00008390-200304000-00013

1 reference

https://api.crossref.org/works/10.1097/00008390-200304000-00013

23 December 2023

1 reference

2 December 2017

volume

13

1 reference

2 December 2017

issue

2

1 reference

2 December 2017

page(s)

189-196

1 reference

Prognostic factors in patients with metastatic malignant melanoma. A multivariate analysis

2 December 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1097/00008390-200304000-00013

Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma

23 December 2023

2

1 reference

https://api.crossref.org/works/10.1097/00008390-200304000-00013

Multi-institutional phase II randomized trial of integrated therapy with cisplatin, dacarbazine, vindesine, subcutaneous interleukin-2, interferon alpha2a and tamoxifen in metastatic melanoma. BREMIM (Biological Response Modifiers in Melanoma)

23 December 2023

3

1 reference

https://api.crossref.org/works/10.1097/00008390-200304000-00013

Cytotoxicity of a selected series of substituted phenols towards cultured melanoma cells

23 December 2023

4

1 reference

https://api.crossref.org/works/10.1097/00008390-200304000-00013

Relationship between melanogenesis, glutathione levels and melphalan toxicity in human melanoma cells

23 December 2023

5

1 reference

https://api.crossref.org/works/10.1097/00008390-200304000-00013

Melanoma cytotoxicity of buthionine sulfoximine (BSO) alone and in combination with 3,4-dihydroxybenzylamine and melphalan

23 December 2023

6

1 reference

https://api.crossref.org/works/10.1097/00008390-200304000-00013

Inhibition of glutathione synthesis augments lysis of murine tumor cells by sulfhydryl-reactive antineoplastics

23 December 2023

7

1 reference

https://api.crossref.org/works/10.1097/00008390-200304000-00013

Ethacrynic acid: a novel radiation enhancer in human carcinoma cells.

23 December 2023

9

1 reference

https://api.crossref.org/works/10.1097/00008390-200304000-00013

Phase I trial of buthionine sulfoximine in combination with melphalan in patients with cancer.

23 December 2023

11

1 reference

https://api.crossref.org/works/10.1097/00008390-200304000-00013

Phase I clinical trial of intravenous L-buthionine sulfoximine and melphalan: an attempt at modulation of glutathione

23 December 2023

12

1 reference

https://api.crossref.org/works/10.1097/00008390-200304000-00013

Modification of chemotherapy by nitroimidazoles

23 December 2023

13

1 reference

https://api.crossref.org/works/10.1097/00008390-200304000-00013

Characterization of the inhibition of glutathione reductase and the recovery of enzyme activity in exponentially growing murine leukemia (11210) cells treated with 1,3-bis(2-chloroethyl)-1-nitrosourea

23 December 2023

14

1 reference

https://api.crossref.org/works/10.1097/00008390-200304000-00013

Carbamoylation of glutathione reductase by N,N-bis(2-chloroethyl)-N- nitrosourea associated with inhibition of multidrug resistance protein (MRP) function

23 December 2023

15

1 reference

https://api.crossref.org/works/10.1097/00008390-200304000-00013

Effects of garlic thioallyl derivatives on growth, glutathione concentration, and polyamine formation of human prostate carcinoma cells in culture

23 December 2023

16

1 reference

https://api.crossref.org/works/10.1097/00008390-200304000-00013

Validated high-performance liquid chromatography-electrochemical method for determination of glutathione and glutathione disulfide in small tissue samples.

23 December 2023

17

1 reference

https://api.crossref.org/works/10.1097/00008390-200304000-00013

Treatment of advanced malignancies with high-dose acetaminophen and N-acetylcysteine rescue

23 December 2023

18

1 reference

https://api.crossref.org/works/10.1097/00008390-200304000-00013

Selective toxicity of buthionine sulfoximine (BSO) to melanoma cells in vitro and in vivo

23 December 2023

20

1 reference

https://api.crossref.org/works/10.1097/00008390-200304000-00013

Susceptibility of human melanoma cells to oxidative stress including UVA radiation

23 December 2023

21

1 reference

https://api.crossref.org/works/10.1097/00008390-200304000-00013

Phase II trial of recombinant leukocyte A interferon (IFN-alpha 2A) plus 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and the combination cimetidine with BCNU in patients with disseminated malignant melanoma

23 December 2023

22

1 reference

https://api.crossref.org/works/10.1097/00008390-200304000-00013

Chemotherapy of malignant melanoma

23 December 2023

23

1 reference

https://api.crossref.org/works/10.1097/00008390-200304000-00013

A randomised phase II study of carmustine alone or in combination with tumour necrosis factor in patients with advanced melanoma

23 December 2023

24

1 reference

https://api.crossref.org/works/10.1097/00008390-200304000-00013

Temporal changes in insulin sensitivity following the development of acute liver failure secondary to acetaminophen

23 December 2023

25

1 reference

https://api.crossref.org/works/10.1097/00008390-200304000-00013

Use of lymphocytes for assessing ethanol-mediated alterations in the expression of hepatic cytochrome P4502E1

23 December 2023

26

1 reference

https://api.crossref.org/works/10.1097/00008390-200304000-00013

23 December 2023

Identifiers

1 reference

2 December 2017

1 reference